Cargando…
Personalization of Targeted Therapy in Advanced Thyroid Cancer
Although generally the prognosis of differentiated thyroid carcinoma (DTC) is good, approximately 5% of people are likely to develop metastases which fail to respond to radioactive iodine, and other traditional therapies, exhibiting a more aggressive behavior. Nowadays, therapy is chosen and impleme...
Autores principales: | Fallahi, Poupak, Ferrari, Silvia Martina, Mazzi, Valeria, Vita, Roberto, Benvenga, Salvatore, Antonelli, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064559/ https://www.ncbi.nlm.nih.gov/pubmed/24955027 http://dx.doi.org/10.2174/1389202915999140404101902 |
Ejemplares similares
-
New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015) -
Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015) -
Environmental Issues in Thyroid Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2017) -
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017) -
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2021)